Articles by Maria Fernández García

Dangerous Side-effects of New Treatments

Raúl Ludeña, Raúl Ptaszynski Lanza, Beatriz Nieves Ureña, et al

Published:

Citation: European Cardiology Review 2026;21(Suppl 1):41.

DOI:

https://doi.org/10.15420/ecr.2026.21.s1.PO33
Oral Pharmacological Chaperone Therapy in Fabry Disease

María Salgado, Alberto Alen Andrés, Maria Fernández García, et al

Published:

Citation: European Cardiology Review 2026;21(Suppl 1):39.

DOI:

https://doi.org/10.15420/ecr.2026.21.s1.PO31
Pharmacotherapeutic Management of a Complex Case of Cardiac Tamponade in a Patient with Panhypopituitarism and Adrenal Insufficiency

Adela Castro Garcia, Maria Fernández García, Beatriz Nieves Ureña, et al

Published:

Citation: European Cardiology Review 2026;21(Suppl 1):37.

DOI:

https://doi.org/10.15420/ecr.2026.21.s1.PO29
Platinum-based Chemotherapy and Its Cardiovascular Impact on Long-term Survival in Male Patients with Germ Cell Tumours

Maria Fernández García, Alberto Alen Andrés, Beatriz Nieves Ureña, et al

Published:

Citation: European Cardiology Review 2026;21(Suppl 1):28.

DOI:

https://doi.org/10.15420/ecr.2026.21.s1.PO20
Cardiac Amyloidosis Masked by Ischaemic Heart Disease: A Case Emphasising Diagnostic Red Flags in an Elderly Patient

Maria Fernández García, Beatriz Nieves Ureña, Alberto Alen Andrés, et al

Published:

Citation: European Cardiology Review 2026;21(Suppl 1):27.

DOI:

https://doi.org/10.15420/ecr.2026.21.s1.PO19
Are the Patients We Refer for Mitraclip Receiving Optimal Medical Therapy? Experience in a Tertiary Care Hospital

Beatriz Nieves Ureña, Raúl Ludeña, Raúl Ptaszynski Lanza, et al

Published:

Citation: European Cardiology Review 2026;21(Suppl 1):17.

DOI:

https://doi.org/10.15420/ecr.2026.21.s1.PO11
Cardiac Devices for Myotonic Dystrophy Management: Results From a National Cohort

Alberto Alen Andrés, Raúl Ptaszynski Lanza, Beatriz Nieves Ureña, et al

Published:

Citation: European Cardiology Review 2026;21(Suppl 1):16.

DOI:

https://doi.org/10.15420/ecr.2026.21.s1.PO10
Myosin Inhibitors in Hypertrophic Obstructive Cardiomyopathy: Experience with Mavacamten in a National Referral Center

Alberto Alen Andrés, María Salgado, Maria Fernández García, et al

Published:

Citation: European Cardiology Review 2026;21(Suppl 1):15.

DOI:

https://doi.org/10.15420/ecr.2026.21.s1.PO9
Calcium Channel Blockers: The Only Pharmacological Choice

Raúl Ludeña, Raúl Ptaszynski Lanza, Ana Las Hayas, et al

Published:

Citation: European Cardiology Review 2026;21(Suppl 1):9.

DOI:

https://doi.org/10.15420/ecr.2026.21.s1.PO5